How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?

BACKGROUND: Uncertainty in real-world product profiles is the main barrier to pharmaceutical market access. Managed entry agreements (MEAs) are the formal arrangements to overcome these uncertainties. Despite the extensive experience of developed countries in implementing such agreements, the experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shobeiri, Nikta, Peiravian, Farzad, Yousefi, Nazila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brieflands 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420212/
https://www.ncbi.nlm.nih.gov/pubmed/36060922
http://dx.doi.org/10.5812/ijpr-126916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420212/
https://www.ncbi.nlm.nih.gov/pubmed/36060922
http://dx.doi.org/10.5812/ijpr-126916

Ejemplares similares